Search

Your search keyword '"Meloni, M.F."' showing total 8 results
Start Over Author "Meloni, M.F."
8 results on '"Meloni, M.F."'

4. Die EFSUMB-Leitlinien und Empfehlungen für den klinischen Einsatz des kontrastverstärkten Ultraschalls (CEUS) bei nicht-hepatischen Anwendungen: Update 2017 (Kurzversion)

Author

Sidhu, P.S., Cantisani, V., Dietrich, C.F., Gilja, O.H., Saftoiu, A., Bartels, E., Bertolotto, M., Calliada, F., Clevert, D.-A., Cosgrove, D., Deganello, A., D'Onofrio, M., Drudi, F.M., Freeman, S., Harvey, C., Jenssen, C., Jung, E.-M., Klauser, A.S., Lassau, N., Meloni, M.F., Leen, E., Nicolau, C., Nolsoe, C., Piscaglia, F., Prada, F., Prosch, H., Radzina, M., Savelli, L., Weskott, H.-P., Wijkstra, H., Signal Processing Systems, and Biomedical Diagnostics Lab

Subjects
urinary tract, Adult, Male, neurology, Liver Neoplasms, head/neck, Sulfur Hexafluoride, Contrast Media, musculoskeletal system, Liver/diagnostic imaging, head, Image Enhancement, neck, vascular, Ultrasonography/standards, Practice Guidelines as Topic, Humans, Female, Phospholipids
Abstract

The updated version of the EFSUMB guidelines on the application of non-hepatic contrast-enhanced ultrasound (CEUS) deals with the use of microbubble ultrasound contrast outside the liver in the many established and emerging applications.

Published
2018

5. The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Short Version)

Author

Sidhu, P.S., Cantisani, V., Dietrich, C.F., Gilja, O.H., Saftoiu, A., Bartels, E., Bertolotto, M., Calliada, F., Clevert, D.-A., Cosgrove, D., Deganello, A., D'Onofrio, M., Drudi, F.M., Freeman, S., Harvey, C., Jenssen, C., Jung, E.-M., Klauser, A.S., Lassau, N., Meloni, M.F., Leen, E., Nicolau, C., Nolsoe, C., Piscaglia, F., Prada, F., Prosch, H., Radzina, M., Savelli, L., Weskott, H.-P., Wijkstra, H., Sidhu, P.S., Cantisani, V., Dietrich, C.F., Gilja, O.H., Saftoiu, A., Bartels, E., Bertolotto, M., Calliada, F., Clevert, D.-A., Cosgrove, D., Deganello, A., D'Onofrio, M., Drudi, F.M., Freeman, S., Harvey, C., Jenssen, C., Jung, E.-M., Klauser, A.S., Lassau, N., Meloni, M.F., Leen, E., Nicolau, C., Nolsoe, C., Piscaglia, F., Prada, F., Prosch, H., Radzina, M., Savelli, L., Weskott, H.-P., and Wijkstra, H.

Abstract

The updated version of the EFSUMB guidelines on the application of non-hepatic contrast-enhanced ultrasound (CEUS) deals with the use of microbubble ultrasound contrast outside the liver in the many established and emerging applications.

Published
2018

8. Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver-Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS

Author

Nitin Chaubal, Maria Franca Meloni, Ioan Sporea, Peter N. Burns, Masatoshi Kudo, Xin-Wu Cui, Christoph F. Dietrich, Dirk-André Clevert, Yasunori Minami, Nathalie Lassau, Fuminori Moriyasu, Xiaoyan Xie, Andrej Lyshchik, Andre Ignee, Paul S. Sidhu, Adrian Saftoiu, Mirko D'Onofrio, Maria Cristina Chammas, Yuko Kono, Jean Michel Correas, Jae Young Lee, Guido Torzilli, Carlos Nicolau, Pintong Huang, Ping Liang, Won Jae Lee, Adrian Lim, Yi Dong, J. Brian Fowlkes, Richard G. Barr, Rongqin Zheng, Odd Helge Gilja, Fabio Piscaglia, Christian Pállson Nolsøe, Annalisa Berzigotti, Byung Ihn Choi, Christian Jenssen, Vito Cantisani, Dietrich C.F., Nolsoe C.P., Barr R.G., Berzigotti A., Burns P.N., Cantisani V., Chammas M.C., Chaubal N., Choi B.I., Clevert D.-A., Cui X., Dong Y., D'Onofrio M., Fowlkes J.B., Gilja O.H., Huang P., Ignee A., Jenssen C., Kono Y., Kudo M., Lassau N., Lee W.J., Lee J.Y., Liang P., Lim A., Lyshchik A., Meloni M.F., Correas J.M., Minami Y., Moriyasu F., Nicolau C., Piscaglia F., Saftoiu A., Sidhu P.S., Sporea I., Torzilli G., Xie X., and Zheng R.

Subjects
medicine.medical_specialty, 2019-20 coronavirus outbreak, Acoustics and Ultrasonics, Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Biophysics, Contrast Media, Guideline, 030218 nuclear medicine & medical imaging, Food and drug administration, 03 medical and health sciences, 0302 clinical medicine, medicine, Humans, Radiology, Nuclear Medicine and imaging, Medical physics, 610 Medicine & health, Ultrasonography, Interventional, Ultrasonography, Radiological and Ultrasound Technology, Liver Diseases, Liver Neoplasms, Liver, Good clinical practice, Contrast-enhanced ultrasound, World Federation for Ultrasound in Medicine and Biology, 030211 gastroenterology & hepatology
Abstract

The present, updated document describes the fourth iteration of recommendations for the hepatic use of contrast-enhanced ultrasound, first initiated in 2004 by the European Federation of Societies for Ultrasound in Medicine and Biology. The previous updated editions of the guidelines reflected changes in the available contrast agents and updated the guidelines not only for hepatic but also for non-hepatic applications. The 2012 guideline requires updating as, previously, the differences in the contrast agents were not precisely described and the differences in contrast phases as well as handling were not clearly indicated. In addition, more evidence has been published for all contrast agents. The update also reflects the most recent developments in contrast agents, including U.S. Food and Drug Administration approval and the extensive Asian experience, to produce a truly international perspective. These guidelines and recommendations provide general advice on the use of ultrasound contrast agents (UCAs) and are intended to create standard protocols for the use and administration of UCAs in liver applications on an international basis to improve the management of patients.

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results